Targeting Grancalcin Accelerates Wound Healing by Improving Angiogenesis in Diabetes
Advanced Science · 2024-04 · 11 (14)
DOI: 10.1002/advs.202305856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 02.02.2024. Verfasst von Peng Xiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Calcium-Binding Proteins. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Key field Research and Development Program of Hunan province.
Themen: Wundversorgung, Diabetes mellitus
Abstract (Originalsprache)
Chronic diabetic wounds are a serious complication of diabetes and often result in limb amputations and confer high mortality rates. The proinflammatory secretome in the wound perpetuates defective neovascularization and contributes to dysregulated tissue repair. This study aims to design a gelatin methacrylamide (GelMA) hydrogel to sustained the release of grancalcin‐neutralizing antibody (GCA‐NAb) and evaluate it as a potential scaffold to promote diabetic wound healing. Results show that the expression of grancalcin(GCA), a protein secreted by bone marrow‐derived immune cells, is elevated in the wound sites of individuals and animals with diabetic ulcers. Genetic inhibition of grancalcin expression accelerates vascularization and healing in an animal model. Mechanistic studies show that grancalcin binds to transient receptor potential melastatin 8(TRPM8) and partially inactivates its downstream signaling pathways, thereby impairing angiogenesis in vitro and ex vivo. Systemic or topical administration of a GCA‐NAb accelerate wound repair in mice with diabetes. The data suggest that GCA is a potential therapeutic target for the treatment of diabetic ulcers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Endocrinology Research Center, Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan, 410008, China.
- Department of Burn Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
ORCID-Profile: Peng Xiang, Yongjun Zheng
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Key field Research and Development Program of Hunan province
- Science Fund for Distinguished Young Scholars of Hunan Province
- Shanghai Rising-Star Program
- Youth Medical Talents-Specialist Program
- Changhong Talent Plan of Changhai Hospital
Zitieren
APA
Xiang, P., Jiang, M., Chen, X., Chen, L., Cheng, Y., Luo, X., Zhou, H., & Zheng, Y. (2024). Targeting Grancalcin Accelerates Wound Healing by Improving Angiogenesis in Diabetes. Advanced Science, 11(14). https://doi.org/10.1002/advs.202305856
Vancouver
Xiang P, Jiang M, Chen X, Chen L, Cheng Y, Luo X, et al. Targeting Grancalcin Accelerates Wound Healing by Improving Angiogenesis in Diabetes. Advanced Science. 2024;11(14). doi:10.1002/advs.202305856
BibTeX
@article{Xiang2024,
author = {Xiang, Peng and Jiang, Meng and Chen, Xin and Chen, Linyun and Cheng, Yalun and Luo, Xianghang and Zhou, Haiyan and Zheng, Yongjun},
title = {Targeting Grancalcin Accelerates Wound Healing by Improving Angiogenesis in Diabetes},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {14},
doi = {10.1002/advs.202305856}
}
EUVIMED